Search clinical trials for: Modulation of FiO2

Total 10000 results

National Cancer Institute (NCI)

Completed

Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery

Cervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Cancer | Stage IVB Cervical Cancer | Cervical Adenosquamous Cell Carcinoma

Canada
National Cancer Institute (NCI)

Completed

Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Stage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube Cancer | Stage IIIA Fallopian Tube Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIC Fallopian Tube Cancer and other conditions

Canada
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Terminated

Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)

Liver Cancer

United States
Institute of Oncology Ljubljana

Unknown

Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study (CRAB)

Locally Advanced Rectal Cancer

Slovenia
University College Cork
Health Research Board, Ireland

Completed

The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease Patients

Supplementation | Crohn's Disease | Bone Health

Ireland
Genentech, Inc.

Terminated

A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R)

Renal Cell Carcinoma
National Cancer Institute (NCI)

Completed

SU5416 and Carboplatin to Treat Ovarian Cancer

Ovarian Cancer | Peritoneal Neoplasm | Fallopian Tube Neoplasm

United States
Zhejiang Cancer Hospital

Not yet recruiting

Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPC

Locally Advanced Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer

Chemotherapy | Colorectal Cancer Metastatic | Immunotherapy | Targeted Therapy | Radiotherapy, Intensity-Modulated

China
Hansoh BioMedical R&D Company

Recruiting

HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

China
Medical University of Lublin

Recruiting

Xanthohumol as an Adjuvant in the Treatment of Septic Shock

Pneumonia | Septic Shock | ARDS

Poland
Fudan University

Not yet recruiting

DEBIRI Combined With Chemotherapy and Bevacizumab in the Treatment of Unresectable Colorectal Cancer Liver Metastases (DEBIRI)

Colorectal Neoplasms

China
Universidad Autonoma de Nuevo Leon
LifeNet Health; Lynch Biologics LLC

Recruiting

Periodontal Regeneration With Recombinant Human Platelet Derived Growth Factor (rH-PDGF-BB) and Allograft

Periodontal Diseases

Mexico
Sun Yat-sen University

Recruiting

Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria) (BEST)

Hepatocellular Carcinoma

China
South West Sydney Local Health District

Recruiting

Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure (VETtiPAT-ARF)

Acute Respiratory Failure | Hypercoagulability | Fibrinolysis Shutdown

Australia
Fudan University

Recruiting

FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

Liver Metastasis Colon Cancer

China
National Cancer Institute, Naples

Recruiting

Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer (ARBITRATION)

Metastatic Colorectal Cancer

Italy
Kodiak Sciences Inc

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK (DAYBREAK)

Wet Age-related Macular Degeneration

United States, Puerto Rico
Centre Hospitalier Intercommunal de Toulon La Seyne...
Centre Hospitalier Universitaire de Saint Etienne; Investigation network on...

Completed

Diagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower Limbs (ULTREC)

Deep Vein Thrombosis

France
EyePoint Pharmaceuticals, Inc.

Completed

Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (DAVIO2)

Wet Age-related Macular Degeneration

United States
Hospital Clinic of Barcelona
Fundacion Clinic per a la Recerca Biomédica; Instituto de Salud Carlos III

Active, not recruiting

CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2). (CHOICE2)

Stroke, Acute | Stroke, Acute Ischemic

Spain
Istituto Ortopedico Rizzoli

Terminated

Evaluation of the Use of Tranexamic Acid in Tibial Osteotomies

Osteoarthritis | Monocompartimental Tibiofemoral Osteoarthritis

Italy
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Completed

601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)

Branch Retinal Vein Occlusion

China
National Cancer Institute (NCI)

Completed

Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

Neurofibromatosis Type 1 | Recurrent Childhood Pilocytic Astrocytoma | Recurrent Childhood Visual Pathway Glioma

United States, Canada, Australia, New Zealand
St. Erik Eye Hospital

Completed

Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion with Macular Edema

Sweden
Xoft, Inc.
Icad, Inc.

Terminated

Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab (IORT)

Glioblastoma | GBM | Recurrent Glioblastoma | Recurrent GBM

United States
Cortice Biosciences, Inc.

Suspended

Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma

Glioblastoma Multiforme

United States
Dar El Oyoun Hospital
Cairo University

Completed

Focal Laser Single Intravitreal Ranibizumab Retinal Artery Macroaneurysm. (RAM)

Retinal Artery Macroaneurysm

Egypt
University of Sao Paulo General Hospital

Completed

CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19

Covid19 | Acute Kidney Injury

Brazil
Wake Forest University Health Sciences

Completed

The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery (TXA)

Acetabular Fractures

United States
Melbourne Health

Completed

Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (TASTEa)

Stroke, Acute, Stroke Ischemic

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Trial to Evaluate the Safety and Tolerability of Repeated Intravitreal Injection of IBI302 in Neovascular AMD Patients

Neovascular Age-related Macular Degeneration

China
Aswan University Hospital

Completed

Reducing Blood Loss During Cesarean Hysterectomy for Placenta Accreta Spectrum

Cesarean Section Complications

Egypt
Hôpital Necker-Enfants Malades
Bambino Gesù Hospital and Research Institute

Terminated

Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery

Acquired Platelet Function Disorder

France
M.D. Anderson Cancer Center
Genentech, Inc.

Completed

A Pilot Study of Bevacizumab for Neoplastic Meningitis

Neoplastic Meningitis

United States
Washington University School of Medicine
Regeneron Pharmaceuticals

Completed

Intravitreal Aflibercept Injection for Radiation Retinopathy

Macular Edema | Radiation Retinopathy

United States
Samsung Medical Center

Unknown

Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC

Non Small Cell Lung Cancer
University of Ulm

Completed

Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage

Myeloproliferative Neoplasms

Germany
Genentech, Inc.

Completed

A Study of the Safety and Pharmacology of MetMAb (PRO143966), a Monovalent Antagonist Antibody to the Receptor C-Met, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid Tumors

Solid Cancers
Medtronic Neurovascular Clinical Affairs

Completed

Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial (SWIFT PRIME)

Acute Ischemic Stroke

United States
Centre Hospitalier Universitaire de Saint Etienne
LEO Pharma

Completed

Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer (METRO B)

Lymphoma | Multiple Myeloma

France
Galena Biopharma, Inc.

Completed

A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

Thrombocytosis | Myeloproliferative Neoplasms

United States
Max Sung

Completed

Gene Therapy in Treating Women With Metastatic Breast Cancer

Breast Cancer

United States
Hoffmann-La Roche

Terminated

A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.

Non-Squamous Non-Small Cell Lung Cancer

Spain
Herbert Hurwitz, MD
National Cancer Institute (NCI)

Completed

Bevacizumab in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
Aalborg University Hospital
Medtronic

Withdrawn

Interruptions in the Coagulationsystem in Relation With Cardiac Surgery - A Study Comparing Two Heparinization Strategies During On-pump Cardiac Surgery

Cardiac Surgery

Denmark
University of Chicago
Celgene Corporation

Completed

Cetuximab and Lenalidomide in Head and Neck

Squamous Cell Carcinoma

United States
Zhejiang University

Unknown

Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC

Non Small Cell Lung Cancer

China
Attila Vajas
Semmelweis University

Unknown

Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone (VITARM)

Diabetic Retinopathy

Hungary
Celgene Corporation

Completed

A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes

Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)

United States

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations